The role of thymidylate synthase in cellular regulation

Advances in Enzyme Regulation

Volumn 36, Issue , 1996, Pages 143-163

  Chu, Edward ^a   Allegra, Carmen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10-METHYLENETETRAHYDROFOLATE; 5-FLUOROURIDINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FLOXURIDINE PHOSPHATE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MESSENGER RNA; RNA BINDING PROTEIN; TETRAHYDROFOLIC ACID DERIVATIVE; THYMIDYLATE SYNTHASE; TOMUDEX; URIDINE; URIDINE PHOSPHATE;

CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CULTURE; COLON TUMOR; COLORECTAL CARCINOMA; CONFERENCE PAPER; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CELL; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN PURIFICATION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SERODIAGNOSIS; SOUTHERN BLOTTING;

EID: 0030472807     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/0065-2571(95)00004-6     Document Type: Conference Paper

References (70)

1. G. A. SOTOS, L. M. GROGAN and C. J. ALLEGRA, Preclinical and clinical aspects of biomodulation of 5-fluorouracil, Cancer Treatment Reviews 20, 11-49 (1994).
2. H. M. PINEDO and G. F. J. PETERS, Fluorouracil: Biochemistry and pharmacology, J. Clin. Oncol. 6, 1653-1664 (1988).
3. Y. SUIMADA, M. YOSHINO, A. WAKUI, I. NAKAO, K. FUTATSUKI, Y. SAKATA, M. KAMBE, T. TAGUCHI and N. OGAWA, Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer, J. Clin. Oncol. 11, 909-913 (1993).
4. D. CUNNINGHAM, J. ZALCBERG, E. FRANCOIS, E. VAN CUTSEM, J. H. SCHORNAGEL, A. ADENIS, M. GREEN, H. STARKHAMMER, A. HANRAHAN, P. ELLIS and M. AZAB, Tomudex (ZD1694) a new thymidylate synthase inhibitor with good antitumor activity in advanced colorectal cancer (ACC), Proc. Am. Soc. Clin. Onc. 13, 199 (1994).
5. C. G. MOERTEL, Chemotherapy for colorectal cancer, N. Engl. J. Med. 330, 1136-1142 (1994).
6. M. FRIEDKIN and A. KORNBERG, Chemical Basis of Heredity, pp. 609-614. Johns Hopkins Press, Maryland (1957).
7. P. V. DANENBERG, Thymidylate synthase: A target enzyme in cancer chemotherapy, Biochim. Biophys. Acta. 473, 73-79 (1977).
8. L. W. HARDY, J. S. FINER-MOORE, W. R. MONTFORT, M. O. JONES, D. V. SANTI and R. M. STROUD, Atomic structure of thymidylate synthase: Target for rational drug design, Science 235, 448-455 (1987).
9. W. L. WASHTIEN, Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil, Mol. Pharmacol. 25, 171-177 (1984).
10. P. G. JOHNSTON, J. C. DRAKE, J. TREPEL and C. J. ALLEGRA, Immunological quantitation of thymidylate synthase using the monoclonal antibody TS106 in 5-FU sensitive and resistant human cancer cell lines, Cancer Res. 52, 4306-4312 (1992).
11. S. M. SWAIN, M. E. LIPPMAN, E. F. EGAN, J. C. DRAKE, S. M. STEINBERG and C. J. ALLEGRA, 5-Fluorouracil and high-dose leucovorin in previously treated patients with raetastatic breast cancer, J. Clin. Oncol. 7, 890-899 (1989).
12. H. R. ALEXANDER, J. L. GREM, J. M. HAMILTON, H. I. PASS, M. HONG, D. L. FRAKER, S. M. STEINBERG, N. McATEE and C. J. ALLEGRA, Thymidylate synthase protein expression is associated with response following neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma, Cancer J. 1, 49-54 (1995).
13. N. WOLMARK, H. ROCKETTE, B. FISHER, D. L. WICKERHAM, C. REDMOND, E. R. FISHER, J. JONES, E. P. MAMOUNAS, L. ORE, N. J. PETRELLI, C. L. SPURR, N. DIMITROV, E. H. ROMOND, C. M. SUTHERLAND, C. G. KARDINAL, P. A. DEFUSCO and P. JOCHIMSEN, The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03, J. Clin. Oncol. 11, 1879-1887 (1993).
14. E. CHU and C. J. ALLEGRA, Mechanisms of clinical resistance to 5-FU chemotherapy, Advances in Cancer Res. (in press).
15. L. G. NAVALGUND, C. ROSSANA, A. L. MUENCH and L. F. JOHNSON, Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts, J. Biol. Chem. 255, 7386-7390 (1980).
16. C. H. JENH, L. G. RAO and L. F. JOHNSON, Regulation of thymidylate synthase enzyme synthesis in 5-fluorodeoxyuridine-resistant mouse fibroblasts during the transition from the resting to growing state, J. Cell. Physiol. 122, 149-154 (1985).
17. D. AYUSAWA, K. SHIMIZU, H. KOYAMA, S. KANEDA, K. TAKEISHI and T. SENO, Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate, J. Mol. Biol. 190, 559-567 (1986).
18. K. KEYOMARSI, J. SAMET, G. MOLNAR and A. B. PARDEE, The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme, J. Biol. Chem. 268, 15142-15149 (1993).
19. E. CHU, J. C. DRAKE, D. M. KOELLER, S. ZINN, C. A. JAMIS-DOW, G. C. YEH and C. J. ALLEGRA, Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines, Mol. Pharm. 39, 136-143 (1991).
20. S. COPUR, A. AIBA, J. C. DRAKE, C. J. ALLEGRA and E. CHU, Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil, Biochem. Pharmacol. 49, 1419-1426 (1995).
21. K. D. DANENBERG and P. V. DANENBERG, Activity of thymidylate synthetase and its inhibition by 5-fluorouracil in highly enzyme-overproducing cells resistant to 10-propargyl-5,8-dideazafolate, Mol. Pharmacol. 36, 219-223 (1989).
22. C. P. SPEARS, A. H. SHAHINIAN, R. G. MORAN, C. HEIDELBERGER and T. H. CORBETT, In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil sensitive and -resistant murine colon adenocarcinomas, Cancer Res. 42, 450-456 (1982).
23. M. H. O. BERNE, B. G. GUSTAVSSON, O. ALMERSJO, P. C. SPEARS and R. FROSING, Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma, Cancer Chemother. Pharmacol. 16, 237-242 (1986).
24. K. KEYOMARSI and R. G. MORAN, Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells, J. Biol. Chem. 263, 14402-14409 (1988).
25. C. L. VAN DER WILT, H. M. PINEDO, K. SMIT and G. J. PETERS, Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors, Cancer Res. 52, 4922-4928 (1992).
26. S. M. SWAIN, M. E. LIPPMAN, E. F. EGAN, J. C. DRAKE, S. M. STEINBERG and C. J. ALLEGRA, 5-Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer, J. Clin. Oncol. 7, 890-899 (1989).
27. E. CHU, S. ZINN, D. BOARMAN and C. J. ALLEGRA, Interaction of gamma Interferon and 5-fluorouracil in the H630 human colon carcinoma cell line, Cancer Res. 50, 5834-5840 (1990).
28. E. CHU, D. M. KOELLER, P. G. JOHNSTON, S. ZINN and C. J. ALLEGRA, Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma, Mol. Pharmacol. 43, 527-533 (1993).
29. E. CHU, D. M. KOELLER, J. L. CASEY, J. C. DRAKE, B. A. CHABNER, P. C. ELWOOD, S. ZINN and C. J. ALLEGRA, Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase, Proc. Natl. Acad. Sci. USA 88, 8977-8981 (1991).
30. E. CHU, D. VOELLER, D. M. KOELLER, J. C. DRAKE, C. H. TAKIMOTO, G. F. MALEY, F. MALEY and C. J. ALLEGRA, Identification of an RNA binding site for human thymidylate synthase, Proc. Natl. Acad. Sci. USA 90, 517-521 (1993).
31. M. R. LERNER and J. A. STEITZ, Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus, Proc. Natl. Acad. Sci. USA 76, 5495-5499 (1979).
32. J. A. STEITZ, Immunoprecipitation of ribonucleoproteins using autoantibodies, Methods Enzymol. 180, 468-481 (1989).
33. A. BERNARDI and P.-F. SPAHR, Nucleotide sequence at the binding site for coat protein on RNA of bacteriophage R17, Proc. Natl. Acad. Sci. USA 69, 3033-3037 (1972).
34. J. L. YATES, A. E. ARFSTEN and M. NOMURA, In vitro expression of Escherichia coli ribosomal protein genes: Autogenous inhibition of translation, Proc. Natl. Acad. Sci. USA 77, 1837-1841 (1980).
35. R. B. WINTER, L. MORRISSEY, P. GAUSS, L. GOLD, T. HSU and J. KARAM, Bacteriophage T4 regA protein binds to mRNAs and prevents translation initiation, Proc. Natl. Acad. Sci. USA 84, 7822-7826 (1987).
36. M. ANDRAKE, N. GUILD, T. HSU, L. GOLD, C. TUERK and J. KARAM, DNA polymerase of bacteriophage T4 is an autogenous translational represser, Proc. Natl. Acad. Sci. USA 85, 7942-7946 (1988).
37. L. GOLD, Posttranscriptional regulatory mechanisms in Escherichia coli, Annu. Rev. Biochem. 57, 199-233 (1988).
38. J. W. B. HERSHEY, Translational control in mammalian cells, Annu. Rev. Biochem. 60, 717-755 (1991).
39. O. MELEFORS and M. W. HENTZE, Translational regulation by mRNA/protein interactions in eukaryotic cells: Ferritin and beyond, Bioassays 15, 85-90 (1993).
40. M. KOZAK, Structural features in eukaryotic mRNAs that modulate the initiation of translation, J. Biol. Chem. 266, 19867-19870 (1991).
41. J. CAREY, V. CAMERON, P. L. DE HASETH and O. C. UHLENBECK, Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding site, Biochemistry 22, 2601-2610 (1983).
42. P. J. ROMANIUK and O. C. UHLENBECK, Nucleoside and nucleotide inactivation of the R-17 coat protein: Evidence for a transient covalent RNA-protein bond, Biochemistry 24, 4239-4244 (1985).
43. S. W. KOONTZ and P. R. SCHIMMEL, Aminoacyl-tRNA synthetase-catalyzed cleavage of the glycosidic bond of 5-halogenated uridines, J. Biol. Chem. 254, 12277-12280 (1979).
44. R. M. STARZYK, S. W. KOONTZ and P. SCHIMMEL, A covalent adduct between the uracil ring and the active site of an aminoacyl tRNA synthetase, Nature 298, 136-140 (1982).
45. R. P. LEARY, N. BEAUDETTE and R. L. KISLIUK, Interaction of deoxyuridylate with thymidylate synthetase, J. Biol. Chem. 250, 4864-4868 (1975).
46. P. C. PLESE and R. B. DUNLAP, Sulfhydryl group modification of thymidylate synthetase and its effect on activity and ternary complex formation, J. Biol. Chem. 252, 6139-6144 (1977).
47. D. V. SANTI and P. V. DANENBERG, Folates in pyrimidine nucleotide biosynthesis, pp. 345-398 in Folates and Pteridines (R. L. BLAKELY and S. J. BENKOVIC, eds.) Wiley, New York (1984).
48. E. CHU, D. M. VOELLER, P. F. MORRISON, K. L. JONES, T. TAKECHI, G. F. MALEY, F. MALEY and C. J. ALLEGRA, The effect of reducing reagents on binding of thymidylate synthase protein to thymidylate synthase messenger RNA, J. Biol. Chem. 269, 20289-20293 (1994).
49. K. F. BASTOW, R. PRABHU and Y. C. CHENG, The intracellular content of dihydrofolate reductase: Possibilities for control and implications for chemotherapy, Advan. Enzyme Regul. 22, 15-26 (1984).
50. B. A. DOMIN, S. P. GRILL, K. F. BASTOW and Y. C. CHENG, Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells, Mol. Pharmacol. 21, 478-482 (1982).
51. K. H. COWAN, M. E. GOLDSMITH, M. D. RICCIARDONE, R. LEVINE, E. RUBALCABA and J. JOLIVET, Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene, Mol. Pharmacol. 30, 69-76 (1986).
52. E. CHU, C. H. TAKIMOTO, D. VOELLER, J. L. GREM and C. J. ALLEGRA, Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro, Biochemistry 32, 4756-4760 (1993).
53. J. F. DAVIES II, T. J. DELCAMP, N. J. PRENDERGAST, V. A. ASHFORD, J. H. FREISHEIM and J. KRAUT, Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate, Biochemistry 29, 9467-9479 (1990).
54. C. BYSTROFF and J. KRAUT, Crystal structure of unliganded Escherichia coli dihydrofolate reductase ligand-induced conformational changes and cooperativity in binding, Biochemistry 30, 2227-2239 (1991).
55. J. L. SHERLEY and T. J. KELLY, Regulation of human thymidine kinase during the cell cycle, J. Biol. Chem. 263, 8350-8358 (1988).
56. M. ITO and S. E. CONRAD, Independent regulation of thymidine kinase mRNA and enzyme levels in serum-stimulated cells, J. Biol. Chem. 265, 6954-6960 (1990).
57. M. KNOFLER, C. WALTNER, E. WINTERSBERGER and E. W. MULLNER, Translational repression of endogenous thymidine kinase mRNA in differentiating and arresting mouse cells, J. Biol. Chem. 268, 11409-11416 (1993).
58. R. D. KLAUSNER, T. A. ROUAULT and J. B. HARFORD, Regulating the fate of mRNA: The control of cellular iron metabolism, Cell 72, 19-28 (1993).
59. B. R. HENDERSON, E. MENOTTI, C. BONNARD and J. C. KÜHN, Optimal sequence and structure of iron-responsive elements, J. Biol. Chem. 269, 17481-17489 (1994).
60. E. CHU, D. M. VOELLER, K. L. JONES, T. TAKECHI, G. F. MALEY, F. MALEY, S. SEGAL and C. J. ALLEGRA, Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells, Mol. Cell. Biol. 14, 207-213 (1994).
61. E. CHU, T. TAKECHI, K. L. JONES, D. M. VOELLER, S. M. COPUR, G. F. MALEY, F. MALEY, S. SEGAL and C. J. ALLEGRA, Thymidylate synthase protein binds to c-myc RNA in human colon cancer cells and in vitro, Mol. Cell. Biol. 15, 179-185 (1995).
62. R. D. PROKIPCAK, D. J. HERRICK and J. ROSS, Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA, J. Biol. Chem. 269, 9261-9269.
63. A. J. LEVINE, J. MOMAND and C. A. FINLAY, The p53 tumour suppressor gene, Nature 351, 453-456 (1991).
64. S. J. ULLRICH, C. W. ANDERSON, W. E. MERCER and E. J. APPELA, The p53 tumor suppressor protein, a modulator of cell proliferation, J. Biol. Chem. 267, 15259-15262 (1992).
65. B. VOGELSTEIN and K. W. KINZLER, p53 function and dysfunction, Cell 70, 523-526 (1992).
66. C. C. HARRIS and M. HOLLSTEIN, Clinical implications of the p53 tumor-suppressor gene, New Engl. J. Med. 329, 1318-1327 (1993).
67. W. MALTZMAN and L. CZYZYK, UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells, Mol. Cell. Biol. 4, 1689-1694 (1984).
68. M. B. KASTAN, O. ONYEKWERE, D. SIDRANSKY, B. VOGELSTEIN and R. W. CRAIG, Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 51, 6304-6311 (1991).
69. Q. ZHAN, F. CARRIER and A. J. FORNACE, Induction of cellular p53 activity by DNA-damaging agents and growth arrest, Mol. Cell. Biol. 13, 4242-4250 (1993).
70. E. CHU, S. COPUR, K. L. JONES, S. KALEIF, D. VOELLER, G. F. MALEY, F. MALEY and C. J. ALLEGRA, Thymidylate synthase regulates the translation of p53 mRNA, Proc. Am. Assoc. Cancer Res. 36, 3355 (1995).